CDC FluSurv-NET surveillance data through mid-May 2026 show the cumulative influenza-associated hospitalization rate stabilizing in the mid-80s per 100,000 population, as weekly incidence has fallen to near-zero levels consistent with the typical post-peak decline of U.S. flu seasons. This positioning reflects the market's assessment of official laboratory-confirmed case trends and historical patterns, where the vast majority of season-total hospitalizations occur by April. Implied probabilities above 98% for the 85–90 band indicate strong trader consensus on minimal further accumulation before Week 22 resolution criteria are met. Only substantial late-season reporting revisions or an unprecedented summer surge—both rare based on prior CDC records—would realistically shift the outcome outside this narrow range.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · ActualizadoFlu Hospitalization Rate Week 22, 2026?
Flu Hospitalization Rate Week 22, 2026?
85–90 98.4%
<80 <1%
95–100 <1%
90–95 <1%
NUEVO
NUEVO
12 jun 2026
<80
<1%
80–85
<1%
85–90
98%
90–95
<1%
95–100
<1%
100+
<1%
85–90 98.4%
<80 <1%
95–100 <1%
90–95 <1%
NUEVO
NUEVO
12 jun 2026
<80
$418 Vol.
<1%
80–85
$426 Vol.
<1%
85–90
$1,635 Vol.
98%
90–95
$380 Vol.
<1%
95–100
$391 Vol.
<1%
100+
$387 Vol.
<1%
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.CDC FluSurv-NET surveillance data through mid-May 2026 show the cumulative influenza-associated hospitalization rate stabilizing in the mid-80s per 100,000 population, as weekly incidence has fallen to near-zero levels consistent with the typical post-peak decline of U.S. flu seasons. This positioning reflects the market's assessment of official laboratory-confirmed case trends and historical patterns, where the vast majority of season-total hospitalizations occur by April. Implied probabilities above 98% for the 85–90 band indicate strong trader consensus on minimal further accumulation before Week 22 resolution criteria are met. Only substantial late-season reporting revisions or an unprecedented summer surge—both rare based on prior CDC records—would realistically shift the outcome outside this narrow range.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Mercado abierto: Jun 5, 2026, 3:37 PM ET
Volumen
$3,638Fecha de finalización
12 jun 2026Mercado abierto
Jun 5, 2026, 3:37 PM ETResolver
0x69c47De9D...This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.CDC FluSurv-NET surveillance data through mid-May 2026 show the cumulative influenza-associated hospitalization rate stabilizing in the mid-80s per 100,000 population, as weekly incidence has fallen to near-zero levels consistent with the typical post-peak decline of U.S. flu seasons. This positioning reflects the market's assessment of official laboratory-confirmed case trends and historical patterns, where the vast majority of season-total hospitalizations occur by April. Implied probabilities above 98% for the 85–90 band indicate strong trader consensus on minimal further accumulation before Week 22 resolution criteria are met. Only substantial late-season reporting revisions or an unprecedented summer surge—both rare based on prior CDC records—would realistically shift the outcome outside this narrow range.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Volumen
$3,638Fecha de finalización
12 jun 2026Mercado abierto
Jun 5, 2026, 3:37 PM ETResolver
0x69c47De9D...CDC FluSurv-NET surveillance data through mid-May 2026 show the cumulative influenza-associated hospitalization rate stabilizing in the mid-80s per 100,000 population, as weekly incidence has fallen to near-zero levels consistent with the typical post-peak decline of U.S. flu seasons. This positioning reflects the market's assessment of official laboratory-confirmed case trends and historical patterns, where the vast majority of season-total hospitalizations occur by April. Implied probabilities above 98% for the 85–90 band indicate strong trader consensus on minimal further accumulation before Week 22 resolution criteria are met. Only substantial late-season reporting revisions or an unprecedented summer surge—both rare based on prior CDC records—would realistically shift the outcome outside this narrow range.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado
Cuidado con los enlaces externos.
Cuidado con los enlaces externos.
Preguntas frecuentes